Literature DB >> 8852545

Mechanisms of glycopeptide resistance in enterococci.

M Arthur1, P E Reynolds, F Depardieu, S Evers, S Dutka-Malen, R Quintiliani, P Courvalin.   

Abstract

Inducible resistance to high levels of glycopeptide antibiotics in clinical isolates of enterococci is mediated by Tn1546 or related transposons. Tn1546 encodes the VanH dehydrogenase which reduces pyruvate to D-lactate (D-Lac) and the VanA ligase which catalyses synthesis of the depsipeptide D-alanyl-D-lactate (D-Ala-D-Lac). The depsipeptide replaces the dipeptide D-Ala-D-Ala leading to production of peptidoglycan precursors which bind glycopeptides with reduced affinity. In addition, Tn1546 encodes the VanX dipeptidase and the VanY D,D-carboxypeptidase that hydrolyse the dipeptide D-Ala-D-Ala and the C-terminal D-Ala residue of the cytoplasmic precursor UDP-MurNAC-L-Ala-gamma-D- Glu-L-Lys-D-Ala-D-Ala, respectively. These two proteins act in series to eliminate D-Ala-D-Ala-containing precursors. VanX is required for resistance whereas VanY only slightly increases the level of resistance mediated by VanH, VanA and VanX.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8852545     DOI: 10.1016/s0163-4453(96)80003-x

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  22 in total

1.  [Effects of restrictions on use of vancomycin in a German university hospital].

Authors:  T Glück; H J Linde; E Wiegrebe; N Lehn; M Reng; J Schölmerich
Journal:  Med Klin (Munich)       Date:  2000-02-15

2.  VanE-type vancomycin-resistant Enterococcus faecalis clinical isolates from Australia.

Authors:  Lorena Abadía-Patiño; Keryn Christiansen; Jan Bell; Patrice Courvalin; Bruno Périchon
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

3.  Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil.

Authors:  Luca Guardabassi; Bruno Perichon; Jean van Heijenoort; Didier Blanot; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Attenuating the Selection of Vancomycin Resistance Among Enterococci through the Development of Peptide-Based Vancomycin Antagonists.

Authors:  Ryan W Mull; Alec A Brennan; Brittany R Russ; Yftah Tal-Gan
Journal:  ACS Infect Dis       Date:  2020-10-01       Impact factor: 5.084

5.  Detection of Vancomycin-Resistant Enterococcus Spp. (VRE) from Poultry.

Authors:  H Toosa; S Radu; G Rusul; A R Latif; R A Rahim; N Ahmad; O W Ling
Journal:  Malays J Med Sci       Date:  2001-01

Review 6.  Current guidelines for the treatment and prevention of nosocomial infections.

Authors:  E Bergogne-Bérézin
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

7.  Staphylococcus aureus VRSA-11B is a constitutive vancomycin-resistant mutant of vancomycin-dependent VRSA-11A.

Authors:  Bruno Périchon; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2012-06-18       Impact factor: 5.191

8.  Vancomycin-variable Enterococcus faecium: in vivo emergence of vancomycin resistance in a vancomycin-susceptible isolate.

Authors:  Bryan Coburn; Donald E Low; Samir N Patel; Susan M Poutanen; Dea Shahinas; Alireza Eshaghi; Barbara M Willey; Allison McGeer
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

9.  Genetic basis for vancomycin-enhanced cephalosporin susceptibility in vancomycin-resistant enterococci revealed using counterselection with dominant-negative thymidylate synthase.

Authors:  Christopher J Kristich; Dusanka Djorić; Jaime L Little
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

10.  Effect of adaptation to ethanol on cytoplasmic and membrane protein profiles of Oenococcus oeni.

Authors:  M Graça Silveira; Maja Baumgärtner; Frank M Rombouts; Tjakko Abee
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.